NCT03816345 2026-03-18Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerNational Cancer Institute (NCI)Phase 1 Recruiting300 enrolled
NCT06817889 2026-02-27Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised IndividualsFred Hutchinson Cancer CenterPhase 2 Recruiting60 enrolled